Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Inventory (2022 - 2025)

Jin Medical International's Inventory history spans 4 years, with the latest figure at $4.9 million for Q3 2025.

  • For Q3 2025, Inventory rose 153.23% year-over-year to $4.9 million; the TTM value through Sep 2025 reached $4.9 million, up 153.23%, while the annual FY2025 figure was $4.9 million, 153.23% up from the prior year.
  • Inventory for Q3 2025 was $4.9 million at Jin Medical International, up from $1.9 million in the prior quarter.
  • Across five years, Inventory topped out at $6.7 million in Q3 2022 and bottomed at $1.9 million in Q3 2024.
  • The 4-year median for Inventory is $5.0 million (2023), against an average of $4.7 million.
  • The largest annual shift saw Inventory tumbled 61.53% in 2024 before it surged 153.23% in 2025.
  • A 4-year view of Inventory shows it stood at $6.7 million in 2022, then fell by 24.85% to $5.1 million in 2023, then crashed by 61.53% to $1.9 million in 2024, then soared by 153.23% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Inventory are $4.9 million (Q3 2025), $1.9 million (Q3 2024), and $5.1 million (Q3 2023).